Champions Oncology Reports Record Quarterly Revenue of $13.7 Million

Sep 9, 2022 11:38:02 AM / by Champions Oncology

Hackensack, NJ - September 8, 2022 Champions Oncology, Inc. (Nasdaq: CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its first quarter of fiscal 2023, ended July 31, 2022.

Read More →

Champions Oncology Reports Quarterly Revenue of $12.9 Million

Jul 23, 2022 6:58:54 PM / by Champions Oncology

Hackensack, NJ - July 21, 2022 Champions Oncology, Inc. (Nasdaq: CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for the year and fourth fiscal quarter ended  April 30, 2022.

Read More →

Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics

May 31, 2022 8:33:17 AM / by Champions Oncology

Hackensack, NJ and Toronto, ON – May 31, 2022 Champions Oncology, Inc. (Nasdaq: CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, and Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline, announced today a therapeutic development partnership.

Read More →

Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the ‘Best in Show’ Competition at Bio-IT World Conference & Expo

May 3, 2022 8:53:10 AM / by Champions Oncology

Hackensack, NJ – May 3rd, 2022 - Champions Oncology, Inc. (Nasdaq: CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, announced today that its Lumin Bioinformatics Platform has been selected as a finalist for the ‘Best in Show’ Competition at the upcoming Bio-IT World Conference & Expo. The company will present an overview and live demonstration of the platform to judges on May 4th.

Read More →

Champions Oncology Reports Record Quarterly Revenue of $13.2 Million

Mar 16, 2022 5:24:27 PM / by Champions Oncology

Hackensack, NJ - March 15, 2022 Champions Oncology, Inc. (Nasdaq: CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its third quarter of fiscal 2022, ended  January 31, 2022.

Read More →